studiocasper-1 / iStockphoto.com
Janssen, a subsidiary of Johnson & Johnson, has sued generics company Aurobindo over the filing of an Abbreviated New Drug Application (ANDA).
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Janssen, Aurobindo, Abbreviated New Drug Application, US District Court for the District of New Jersey, Food and Drug Administration, generics
